विधियों की तुलना करें
चुनी हुई विधियों की आमने-सामने समीक्षा करें; भिन्नता वाली पंक्तियाँ रेखांकित हैं।
| हेडेक इम्पैक्ट टेस्ट-6× | EORTC QLQ-C30× | |
|---|---|---|
| क्षेत्र | स्वास्थ्य परिणाम | स्वास्थ्य परिणाम |
| परिवार | Process / pipeline | Process / pipeline |
| उद्भव वर्ष≠ | 2003 | 1993 |
| प्रवर्तक≠ | Mark Kosinski et al. | Nico Aaronson et al. |
| प्रकार≠ | Self-report functional impact questionnaire | Self-report quality of life questionnaire |
| मौलिक स्रोत≠ | Kosinski, M., Bayliss, M. S., Bjorner, J. B., Ware, J. E., Garber, W. H., Batenhorst, A., & Tepper, S. (2003). A six-item short-form survey for measuring headache impact: The HIT-6. Quality of Life Research, 12(8), 963-974. DOI ↗ | Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗ |
| उपनाम | HIT-6, Headache Impact Test, HIT | QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale |
| संबंधित≠ | 4 | 5 |
| सारांश≠ | The HIT-6 is a brief, validated measure of headache impact on daily functioning and quality of life. Developed by Mark Kosinski and colleagues in 2003, this 6-item questionnaire quantifies how headache (migraine or other types) affects work, social activities, sleep, and emotional well-being. It is widely used in headache research, clinical trials, and practice to assess disease burden and treatment benefit. | The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care. |
| ScholarGateडेटासेट ↗ |
|
|